Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07479069

Erector Spinae Plane Block for Pain Control After Open Abdominal Surgery

Effect of Bilateral Erector Spinae Plane Block on Postoperative Opioid Consumption in Open Abdominal Surgeries Under General Anaesthesia

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
46 (actual)
Sponsor
Fatima Memorial Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

his randomized controlled trial aims to evaluate the efficacy of the bilateral erector spinae plane (ESP) block in reducing postoperative opioid consumption in patients undergoing open abdominal surgeries under general anesthesia

Detailed description

Patients undergoing abdominal surgeries experience severe postoperative pain. Conventional pain management methods, including opiates, may pose significant side effects. This study addresses the imperative need for optimizing postoperative pain management by systematically investigating the analgesic effects and complications associated with the bilateral ESP block. The study involves 46 patients allocated into two groups using a lottery method: a control group receiving standard pain control treatment, and an erector spinae block group receiving a bilateral ESP block in addition to standard pain control treatment. Pain intensity will be evaluated using a visual analogue scale (VAS) at 4, 8, 12, and 24 hours after the operation.

Conditions

Interventions

TypeNameDescription
PROCEDUREBilateral Erector Spinae Plane (ESP) BlockAdministered after the induction of general anesthesia and before the surgical incision. Local anesthetic (0.25% ropivacaine or 0.25% bupivacaine) will be injected for a total of 20-40 mL
DRUGStandard Postoperative AnalgesiaPatients receive 1000 mg of IV paracetamol every 6 hours postoperatively. If a patient experiences a Visual Analogue Score (VAS) of more than five at any time, they receive rescue analgesia in the form of nalbuphine 4mg

Timeline

Start date
2025-10-01
Primary completion
2026-03-31
Completion
2026-03-31
First posted
2026-03-18
Last updated
2026-03-18

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT07479069. Inclusion in this directory is not an endorsement.